NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $531,000 | +141.4% | 4,569 | +174.9% | 0.02% | +120.0% |
| Q1 2021 | $220,000 | -88.6% | 1,662 | -94.2% | 0.01% | -81.5% |
| Q1 2020 | $1,934,000 | -73.4% | 28,727 | -66.7% | 0.05% | -59.4% |
| Q4 2019 | $7,270,000 | +7.1% | 86,272 | -5.0% | 0.13% | +10.8% |
| Q3 2019 | $6,791,000 | +90.4% | 90,811 | +61.0% | 0.12% | +110.5% |
| Q2 2019 | $3,567,000 | +933.9% | 56,409 | +688.4% | 0.06% | +1040.0% |
| Q1 2019 | $345,000 | -48.8% | 7,155 | -76.9% | 0.01% | -44.4% |
| Q1 2018 | $674,000 | -0.3% | 30,924 | -7.5% | 0.01% | -10.0% |
| Q4 2017 | $676,000 | -7.5% | 33,445 | -9.1% | 0.01% | -9.1% |
| Q3 2017 | $731,000 | +36.9% | 36,802 | +19.2% | 0.01% | +57.1% |
| Q2 2017 | $534,000 | – | 30,878 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |